- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Abbott India
Market Cap: ₹567.6b
Operates as a pharmaceutical company in India.
500488
₹26,712.05
7D
5.0%
1Y
-21.9%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹407.1b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,402.90
7D
-2.0%
1Y
-26.3%
Sanofi India
Market Cap: ₹79.8b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,466.40
7D
1.8%
1Y
-42.3%